Novo Nordisk reported DKK208.7B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Bausch Health Companies USD 6.52B 544M Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Merck USD 35.02B 8.5B Mar/2026
Novartis USD 27.35B 744M Jun/2026
Novo Nordisk DKK 208.7B 31.38B Jun/2026
Novo Nordisk DKK 31.89B 145.42B Jun/2026
Pacira USD 615.21M 100.25M Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Supernus Pharmaceuticals USD 723.5M 8.08M Jun/2026